Featured Research

from universities, journals, and other organizations

Metformin is safe for patients with advanced heart failure and diabetes mellitus, study shows

Date:
January 9, 2010
Source:
University of California - Los Angeles
Summary:
A new study has shown that metformin, a drug often used in the treatment of diabetes mellitus, is safe for use in treating patients who have both diabetes and advanced heart failure.

A new study has shown that metformin, a drug often used in the treatment of diabetes mellitus, is safe for use in treating patients who have both diabetes and advanced heart failure. The study was published in the Journal of Cardiac Failure by researchers at the David Geffen School of Medicine at UCLA .

Related Articles


"There may be over two million individuals with heart failure and type II diabetes mellitus in the U. S. alone, so this important finding will have fairly broad impact," said Dr. Tamara Horwich, senior author of the study and an assistant professor of medicine in the division of cardiology at the David Geffen School of Medicine at UCLA.

Previous studies have shown that diabetes increases not only the risk of developing heart failure, but also the risk of death among heart failure patients. This is due in large part to the fact that diabetes, because it increases the amounts of sugar and fat circulating in the bloodstream, accelerates the onset of coronary atherosclerosis. This hardening and thickening of blood vessels is the hallmark of atherosclerotic heart disease, the most common cause of death in the country. The optimal treatment for high glucose and fat blood levels among heart failure patients has not been demonstrated.

The new study involved 401 patients of an average age of 56, with type II diabetes and advanced systolic heart failure. This patient cohort was followed for 14 years in a comprehensive heart failure management program.

The study results suggest that, in patients with both advanced heart failure and diabetes, use of metformin is safe, and may be associated with better heart failure survival.

"The diabetes drug metformin previously carried a "black box warning" from the FDA against its use in treating diabetes in heart failure patients," said Horwich. "In fact, many medications commonly used to lower serum glucose levels have theoretic or demonstrated adverse effects on heart failure.

"As a result," she continued, "many physicians have been reluctant to use metformin and other similar medications to treat this patient group. However, our analysis shows that using metformin to treat diabetes in patients with advanced, systolic heart failure is not only safe, but may also play a role in improving outcomes compared to conventional diabetes care."

Dr Gregg Fonarow, Eliot Corday Professor of Cardiovascular Medicine at UCLA and coauthor of this study, noted, "Experimental studies suggest that metformin improves myocardial function via activation of a signaling mechanism (AMP-activated protein kinase) independent of antihyperglycemic effects. Together, these studies suggest that metformin may be cardioprotective by augmenting heart function at the molecular level, and should be further investigated as a treatment for heart failure, irrespective of diabetes."

In a previous study, diabetes with heart failure was shown to be an independent risk factor for progression from asymptomatic ventricular disease to symptomatic heart failure, and a risk factor for death from multiple causes. In the current study, metformin was shown to be safe, and may be associated with favorable clinical outcomes. Patients taking metformin had a significantly lower risk of dying after one year than those not taking the medication. In addition, the study showed that there are potential mechanisms by which metformin may improve cardiac function.

Horwich's research group at the Ahmanson-UCLA Cardiomyopathy Center is now conducting a prospective study to investigate metformin's potential benefits in diabetic heart failure patients.

For this research, Horwich was supported by NIH/NHLB. Fonarow was supported by the Ahmanson Foundation of Los Angeles; he holds the Eliot Corday Chair in Cardiovascular Medicine and Science. Dr. Digish D. Shah, a fellow at UCLA, also participated in the study.


Story Source:

The above story is based on materials provided by University of California - Los Angeles. Note: Materials may be edited for content and length.


Journal Reference:

  1. Digish D. Shah, Gregg C. Fonarow, Tamara B. Horwich. Metformin Therapy and Outcomes in Patients With Advanced Systolic Heart Failure and Diabetes. Journal of Cardiac Failure, 2009; DOI: 10.1016/j.cardfail.2009.10.022

Cite This Page:

University of California - Los Angeles. "Metformin is safe for patients with advanced heart failure and diabetes mellitus, study shows." ScienceDaily. ScienceDaily, 9 January 2010. <www.sciencedaily.com/releases/2010/01/100107132558.htm>.
University of California - Los Angeles. (2010, January 9). Metformin is safe for patients with advanced heart failure and diabetes mellitus, study shows. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2010/01/100107132558.htm
University of California - Los Angeles. "Metformin is safe for patients with advanced heart failure and diabetes mellitus, study shows." ScienceDaily. www.sciencedaily.com/releases/2010/01/100107132558.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins